CVRx, Inc. (CVRX) Financial Statements
CVRx, Inc. (CVRX) reported trailing twelve-month revenue of $61.2M (up 12.0% year on year) and net income of -$52.0M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$41.1M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CVRXCVRx, Inc.Follow CVRX — free
—
Price chart with a free account
- Market cap
- 37.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Revenue | 13.0 | 22.5 | 39.3 | 51.3 | 56.7 | 61.2 | |
| Gross profit | 9.4 | 17.5 | 33.0 | 43.0 | 48.3 | 53.2 | |
| Research & development | 7.5 | 10.0 | 11.6 | 11.1 | 11.1 | 12.4 | |
| Operating income | -26.0 | -42.5 | -43.1 | -59.5 | -51.3 | -48.6 | |
| Pre-tax income | -43.0 | -41.3 | -41.1 | -59.9 | -53.3 | -52.0 | |
| Income tax | 0.1 | 0.1 | 0.1 | 0.1 | -0.0 | -0.0 | |
| Net income | -43.1 | -41.4 | -41.2 | -60.0 | -53.3 | -52.0 | |
| Diluted EPS ($) | -4.16 | -2.02 | -1.99 | -2.65 | -2.04 | -1.97 | |
| Diluted shares (mn) | — | 20.5 | 20.8 | 22.6 | 26.1 | — |
USD millions · SEC XBRL
CVRx, Inc. — questions
- What is CVRx, Inc.'s revenue?
- $61.2M over the twelve months to 2026-06-30, up 12.0% year on year, from its 10-Q and 10-K filings.
- What is CVRx, Inc.'s net income?
- -$52.0M over the twelve months to 2026-06-30.
- What is CVRx, Inc.'s free cash flow?
- -$41.1M over the twelve months to 2026-06-30.
- What are CVRx, Inc.'s diluted earnings per share?
- $-1.97 over the twelve months to 2026-06-30.
Every figure on this page comes from CVRx, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.